Björn Cochlovius - Concepedia

Author

Björn Cochlovius

German Cancer Research Center

Also Known As

Björn Cochlovius, Björn Cochlovius

Publications

662

Citations

H-Index

Concepts

All Affiliations

German Cancer Research Center Heidelberg University Affimed Therapeutics (Germany)Karlsruhe University of Applied Sciences Recombinant Antibody Technology (United Kingdom)

About

Björn Cochlovius is an author at German Cancer Research Center specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	413
2	Immunology	7	7	413
3	Cell Biology	3	3	108
4	Cellular Therapies	1	1	78
5	Microbiology	1	1	56

Björn Cochlovius

Publications

649

Citations

H-Index

Page 1

	Year	Citations
Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics Sergey M Kipriyanov, Gerhard Moldenhauer, Jochen Schuhmacher, Journal of Molecular Biology OncologyImproved Antigen BindingTumor TherapyMedicineImmunology	1999	194
Synergistic Antitumor Effect of Bispecific CD19 × CD3 and CD19 × CD16 Diabodies in a Preclinical Model of Non-Hodgkin’s Lymphoma Sergey M. Kipriyanov, Björn Cochlovius, Holger Schäfer, The Journal of Immunology	2002	90
Treatment of Human B Cell Lymphoma Xenografts with a CD3 × CD19 Diabody and T Cells Björn Cochlovius, Sergey M. Kipriyanov, Marike Stassar, The Journal of Immunology Cell TherapyImmunologyImmunoeditingPathologyImmunotherapeutics	2000	78
Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas Rudolf Schmits, Björn Cochlovius, Gerhard Treitz, International Journal of Cancer	2001	65
Effect of Domain Order on the Activity of Bacterially Produced Bispecific Single-chain Fv Antibodies Sergey M. Kipriyanov, Gerhard Moldenhauer, Michael Braunagel, Journal of Molecular Biology BacteriologyImmunologyBacteriophageDomain OrderAntibody Engineering	2003	56
In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program Björn Cochlovius, Marike Stassar, Oliver Christ, The Journal of Immunology	2000	48
Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity Björn Cochlovius, Marike Stassar, Marco W.J. Schreurs, Immunology Letters VaccinationMucosal VaccinationCross-protectionVaccine DevelopmentImmunology	2002	32
Combined effect of recombinant CD19xCD16 diabody and thalidomide in a preclinical model of human B cell lymphoma Jana Schlenzka, Thomas Moehler, Sergey M. Kipriyanov, Anti-Cancer Drugs ImmunologyPathologyTumor Growth RateImmunotherapyTumor Biology	2004	23
In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells Wolfgang Schmitt, Marike Stassar, Wolfgang Schmitt, Journal of Cancer Research and Clinical Oncology Cancer ImmunosurveillanceVitro InductionMrna-transfected Dendritic CellsT-regulatory CellImmunology	2001	18
Recombinant chimeric OKT3 scFv IgM antibodies mediate immune suppression while reducing T cell activationin vitro Ingrid Choi, Concepción de Inés, Timo Kürschner, European Journal of Immunology	2001	17

Page 1